Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

Clinical trial NCT06057168 · COMPLETED

Trial details

NCT number: NCT06057168
Sponsor: Guerbet
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Tumor, Primary Brain Tumor, Recurrent

Start date: 2023-09-07
Primary completion: 2024-11-28
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.